Researchers hope to undertake clinical studies in multiple cancers, including ovarian cancer, glioblastoma, and others.

In 2024, Professor Sebastian Kobold's research group at LMU University Hospital had already shown that the metabolite ...

Though CAR T cells have been effective against certain blood cancers, they have not been for solid tumors. Now, a new form of ...

It's widely known that breastfeeding impacts the health of both mother and child, but the underlying biology that leads to ...

The first engineered cell therapy has come to the fight against solid tumors. Fox Chase Cancer Center has begun using Tecelra, an FDA-approved treatment for synovial sarcoma.

According to one analyst, the alliance and early data “validate” the oncology work of Vir, which was once purely an ...

A proof-of-concept study opens up an avenue for treating solid tumours that express low levels of a target antigen.

Northwestern Medicine scientists have identified the cellular mechanisms that cause immune cells to differentiate and ultimately lose function during viral infection, findings that could improve ...

Cancer tumors hijack the vagus nerve to communicate with the brain, triggering a hormonal response that suppresses the immune system.

An integrin mutation impairs skin T cell migration, enabling HPV proliferation that causes warts and lesions in a rare genetic dermatological condition.

A new study identifies an extreme but effective way that brain immune cells can prevent the parasite Toxoplasma gondii from ...

As interest in CAR T cells and immune-based oncology therapies increases, efficient phenotyping of cell therapy products ...